Identification of a cytoplasmic linker protein as a potential target for neovascularization

Atherosclerosis

Volumn 233, Issue 2, 2014, Pages 403-409

  Xie, Songbo ^a   Dong, Bin ^a   Sun, Xiaodong ^a   Tala, ^a   He, Xianfei ^a   Zhou, Jun ^a   Liu, Min ^b   Li, Dengwen ^a  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Cardiovascular disease; Cytoplasmic linker protein; Motility; Neovascularization; Polarity

Indexed keywords

CYTOPLASMIC LINKER PROTEIN 170; MICROTUBULE ASSOCIATED PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; COLLAGEN; DRUG COMBINATION; FAT INTAKE; LAMININ; MATRIGEL; PROTEOGLYCAN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE MICROSCOPY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; ANIMAL; ANTAGONISTS AND INHIBITORS; ANTIBODY SPECIFICITY; ATHEROSCLEROSIS; CAPILLARY; CELL MOTION; CELL POLARITY; CYTOLOGY; DRUG COMBINATION; DRUG EFFECTS; ENDOTHELIUM CELL; FAT INTAKE; GENE SILENCING; GROWTH, DEVELOPMENT AND AGING; MOLECULARLY TARGETED THERAPY; NEOVASCULARIZATION, PATHOLOGIC; PATHOPHYSIOLOGY; PHYSIOLOGY; PLAQUE, ATHEROSCLEROTIC;

ANIMALS; ATHEROSCLEROSIS; CAPILLARIES; CELL MOVEMENT; CELL POLARITY; COLLAGEN; DIETARY FATS; DRUG COMBINATIONS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LAMININ; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR TARGETED THERAPY; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; ORGAN SPECIFICITY; PLAQUE, ATHEROSCLEROTIC; PROTEOGLYCANS; RNA, SMALL INTERFERING;

EID: 84896275896     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.01.009     Document Type: Article

References (39)

1. Balsam A., El Kossi M.M., Lord R., et al. Cardiovascular disease on hemodialysis: predictors of atherosclerosis and survival. Hemodial Int 2009, 13:278-285.
2. Frostegard J. Immunity, atherosclerosis and cardiovascular disease. BMC Med 2013, 11:117.
3. Cines D.B., Pollak E.S., Buck C.A., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998, 91:3527-3561.
4. Richards O.C., Raines S.M., Attie A.D. The role of blood vessels, endothelial cells, and vascular pericytes in insulin secretion and peripheral insulin action. Endocr Rev 2010, 31:343-363.
5. Inoue M., Ishida T., Yasuda T., et al. Endothelial cell-selective adhesion molecule modulates atherosclerosis through plaque angiogenesis and monocyte-endothelial interaction. Microvasc Res 2010, 80:179-187.
6. Newcomb E.W., Lukyanov Y., Schnee T., et al. Noscapine inhibits hypoxia-mediated HIF-1alpha expression and angiogenesis invitro: a novel function for an old drug. Int J Oncol 2006, 28:1121-1130.
7. Isner J.M., Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. JClin Invest 1999, 103:1231-1236.
8. Campbell S.C. Advances in angiogenesis research: relevance to urological oncology. JUrol 1997, 158:1663-1674.
9. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
10. Kahlon R., Shapero J., Gotlieb A.I. Angiogenesis in atherosclerosis. Can J Cardiol 1992, 8:60-64.
11. Bareschino M.A., Schettino C., Colantuoni G., et al. The role of antiangiogenetic agents in the treatment of breast cancer. Curr Med Chem 2011, 18:5022-5032.
12. Gridelli C., Rossi A., Maione P. New antiangiogenetic agents and non-small cell lung cancer. Crit Rev Oncol Hemat 2006, 60:76-86.
13. Mancuso A., Sternberg C.N. Colorectal cancer and antiangiogenic therapy: what can be expected in clinical practice?. Crit Rev Oncol Hemat 2005, 55:67-81.
14. Winter P.M., Morawski A.M., Caruthers S.D., et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 2003, 108:2270-2274.
15. Gao J., Sun L., Huo L., et al. CYLD regulates angiogenesis by mediating vascular endothelial cell migration. Blood 2010, 115:4130-4137.
16. Lamalice L., Le Boeuf F., Huot J. Endothelial cell migration during angiogenesis. Circ Res 2007, 100:782-794.
17. Akhmanova A., Mausset-Bonnefont A.L., van Cappellen W., et al. The microtubule plus-end-tracking protein CLIP-170 associates with the spermatid manchette and is essential for spermatogenesis. Genes Dev 2005, 19:2501-2515.
18. Gupta K.K., Joyce M.V., Slabbekoorn A.R., et al. Probing interactions between CLIP-170, EB1, and microtubules. JMol Biol 2010, 395:1049-1062.
19. Watanabe T., Wang S., Noritake J., et al. Interaction with IQGAP1 links APC to Rac1, Cdc42, and actin filaments during cell polarization and migration. Dev Cell 2004, 7:871-883.
20. Sun X., Li F., Dong B., et al. Regulation of tumor angiogenesis by the microtubule-binding protein CLIP-170. Protein Cell 2013, 4:266-276.
21. Shi X., Liu M., Li D., et al. Cep70 contributes to angiogenesis by modulating microtubule rearrangement and stimulating cell polarization and migration. Cell Cycle 2012, 11:1554-1563.
22. Schor A.M., Ellis I., Schor S.L. Collagen gel assay for angiogenesis: induction of endothelial cell sprouting. Angiogenesis Protocols 2001, 46:145-162.
23. Li D., Xie S., Ren Y., et al. Microtubule-associated deacetylase HDAC6 promotes angiogenesis by regulating cell migration in an EB1-dependent manner. Protein Cell 2011, 2:150-160.
24. Ji W.R., Barrientos L.G., Llinas M., et al. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. Biochem Biophys Res Commun 1998, 247:414-419.
25. Lauffenburger D.A., Horwitz A.F. Cell migration: a physically integrated molecular process. Cell 1996, 84:359-369.
26. Ridley A.J., Schwartz M.A., Burridge K., et al. Cell migration: integrating signals from front to back. Science 2003, 302:1704-1709.
27. Webb D.J., Parsons J.T., Horwitz A.F. Adhesion assembly, disassembly and turnover in migrating cells - over and over and over again. Nat Cell Biol 2002, 4:E97-100.
28. Sakakibara A., Horwitz A.F. Mechanism of polarized protrusion formation on neuronal precursors migrating in the developing chicken cerebellum. JCell Sci 2006, 119:3583-3592.
29. Felmeden D.C., Blann A.D., Lip G.Y. Angiogenesis: basic pathophysiology and implications for disease. Eur Heart J 2003, 24:586-603.
30. Moulton K.S. Angiogenesis in atherosclerosis: gathering evidence beyond speculation. Curr Opin Lipidol 2006, 17:548-555.
31. Al Sabti H. Therapeutic angiogenesis in cardiovascular disease. JCardiothorac Surg 2007, 2:49.
32. Deveza L., Choi J., Yang F. Therapeutic angiogenesis for treating cardiovascular diseases. Theranostics 2012, 2:801-814.
33. Hammond H.K., McKirnan M.D. Angiogenic gene therapy for heart disease: a review of animal studies and clinical trials. Cardiovasc Res 2001, 49:561-567.
34. Zachary I., Morgan R.D. Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects. Heart 2011, 97:181-189.
35. Bieling P., Kandels-Lewis S., Telley I.A., et al. CLIP-170 tracks growing microtubule ends by dynamically recognizing composite EB1/tubulin-binding sites. JCell Biol 2008, 183:1223-1233.
36. Kaverina I., Straube A. Regulation of cell migration by dynamic microtubules. Semin Cell Dev Biol 2011, 22:968-974.
37. Fukata M., Watanabe T., Noritake J., et al. Rac1 and Cdc42 capture microtubules through IQGAP1 and CLIP-170. Cell 2002, 109:873-885.
38. Gundersen G.G. Microtubule capture: IQGAP and CLIP-170 expand the repertoire. Curr Biol 2002, 12:R645-R647.
39. Hadi H.A., Carr C.S., Al Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag 2005, 1:183-198.